CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease News Drum dated 20th December 2022

CMFRI, Library (2022) CMFRI signs MoU to launch product from seaweeds to combat fatty liver disease News Drum dated 20th December 2022. News Drum.

Preview

Text News Drum_20-12-2022.pdf Download (38kB) | Preview

Abstract

CMFRI has signed an MoU with a private company dealing with health products for commercial production and marketing Cadalmin LivCure extract. A unique blend of 100% natural bioactive ingredients extracted from select seaweeds, the product is made using eco-friendly technology to improve liver health. It is the ninth nutraceutical developed by the CMFRI.

Item Type:	Article
Subjects:	CMFRI News Clippings
Divisions:	CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division Subject Area > CMFRI-Kochi > Marine Biotechnology, Fish Nutrition and Health Division
Depositing User:	Mr. Augustine Sipson N A
Date Deposited:	28 Dec 2022 07:12
Last Modified:	28 Dec 2022 07:12
URI:	http://eprints.cmfri.org.in/id/eprint/16561

Actions (login required)

View Item